Certified by Founder Lodge
RiverVest Venture Partners
United States - St. Louis, MO
INVESTOR
1 Disclosed Funding Rounds $14,000,000
5 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
RiverVest Venture Partners® is a leading venture capital firm building life science companies to address significant unmet needs of patients and deliver consistently strong returns to investo
| Company | Date | Round | Raised |
|---|---|---|---|
 OncoResponse |
May, 19 ,2023 | Unknown | $14,000,000 |
 Avalyn Pharma Inc. |
September, 28 ,2023 | Series C | $175,000,000 |
 Engrail Therapeutics |
March, 20 ,2024 | Series B | $157,000,000 |
 Bluejay Therapeutics |
May, 10 ,2024 | Series C | $182,000,000 |
 InterVene, Inc. |
October, 08 ,2024 | Series A | $13,000,000 |
Cherry Ventures
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
Theranautilus | $1,200,000 | (Nov 19, 2024)
SuperAnnotate | $36,000,000 | (Nov 19, 2024)
Plantible | $30,000,000 | (Nov 19, 2024)
ANELLO Photonics | Undisclosed Amount | (Nov 19, 2024)
Bluespine | $7,200,000 | (Nov 19, 2024)
